Our results suggest that siRNA-mediated depletion of PKM2 markedly reduced the IC50 index of doxorubicin, paclitaxel, and cisplatin, indicating that PKM2 attenuated the sensitivity of MCF-7 to anti-cancer drugs (Fig. 7). The gene discussed is PKM; the disease is cancer.